Clinical Trial Update: Trial of Afatinib in Pediatric Tumours [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for afatinib in pediatric neuroectodermal tumors and rhabdomyosarcoma (Phase 1/2) has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroectodermal Tumors
• Rhabdomyosarcoma

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neuroectodermal Tumors, Rhabdomyosarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-03-04